recombinant human glutamic acid decarboxylase
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human glutamic acid decarboxylase, covering 2016-12-07 to 2016-12-07. Get the full timeline:
Most recent: Clinical Trial Update: Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects [Phase 2]